Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2007-01-09
2007-01-09
Huff, Sheela J. (Department: 1643)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C424S192100, C435S069700, C530S300000, C530S402000
Reexamination Certificate
active
10006867
ABSTRACT:
The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
REFERENCES:
patent: 5536637 (1996-07-01), Jacobs
patent: 6025156 (2000-02-01), Gwynn et al.
patent: 6124433 (2000-09-01), Falb et al.
patent: 6156500 (2000-12-01), Falb
patent: 6162604 (2000-12-01), Jacob
patent: 6228582 (2001-05-01), Rodier et al.
patent: 6395306 (2002-05-01), Cui et al.
patent: 6414117 (2002-07-01), Levinson
patent: 6465185 (2002-10-01), Goldfine et al.
patent: 6498235 (2002-12-01), Sheppard et al.
patent: 6562343 (2003-05-01), Levinson
patent: 6645499 (2003-11-01), Lal et al.
patent: 6730502 (2004-05-01), Van Hijum et al.
patent: 6737522 (2004-05-01), Sundick et al.
patent: WO 97/38085 (1997-10-01), None
patent: WO 99/24836 (1999-05-01), None
patent: WO 99/63088 (1999-12-01), None
Burgess et al, Journal of Cell Biology vol. 111 Nov. 1990 2129-2138.
Lazar et al Molecular and Cellular Biology Mar 1988 vol. 8 No. 3 1247-1252.
Schwartz et al, Proc Natl Acad Sci USA vol. 84:6408-6411 1987.
Lin et al Biochemistry USA vol. 14:1559-1563 1975.
Fu et al EMBO Journal, 1996, vol. 15, pp. 4392-4401.
Powell et al Pharmacogenesis, 1998, vol. 8, pp. 411-421, abstract.
Vallejo et al Biochimie, 2000, vol. 82, pp. 1129-1133, abstract.
Jang et al Clinical and Experimental Metastasis, 1997, vol. 15, pp. 469-483, Abstract.
Pennica et al PNAS 95:14717-14722, 1998.
Chen et al (Molecular and Cellular Proteomics 1:304-313, 2002.
Genes VI, Benjamin Lewin, 1997, Chapter 29-Regulation of Transcription, 847-48.
Winstead E. R., Genome News Network, “The Evolving Art of Arrays”, www.genomenewsnetwork.org, pp. 1-4, Sep. 15, 2000.
Irving et al. Nature Biotechnology 18:932-933, Sep. 2000.
Oda et al. Virchows Arch. 430:99-105, 1997.
Sugg et al. Clinical Endocrinology 49:629-637, 1998.
Toler et al. Am. J. Obstet. Gynecol. 194:e27-e31, 2006.
Berner et al. Histopathol. 42: 546-554, 2003.
Brooks et al. Am. J. Physiol. Renal Physiol. 284: F218-F228, 2003.
Klein et al. Selection for Genes Encoding Secreted Proteins and Receptors.Proc. Natl. Acad. Sci., 93:7108-7113 (1996).
Database Search, DNA Sequence Alignments [BLASTN 2.2.1 [Jul. 12, 2001], NCBI].
Database Search, Protein Sequence Alignments [BLASTP 2.2.1 [Jul. 12, 2001], NCBI].
Hanna et al.,HER-2
eu Breast Cancer Predictive Testing, Pathology Associates Medical Laboratories, 8:1-2 (1999).
Orntoft et al.,Genome-wide Study of Gene Copy Numbers, Transcripts, and Protein Levels in Pairs of Non-Invasive and Invasive Human Transitional Cell Carcinomas, Molecular&Cellular Proteomics, 1.1:37-45 (2002).
Hyman et al.,Impact of DNA Amplification on Gene Expression Patterns in Breast Cancer1,2Cancer Research, 62:6240-6245 (2002).
Pollack et al.Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. PNAS, 99(20):12963-12968 (2002).
Allman, et al. 1996,Blood, vol. 87, No. 12, pp. 5257-5288.
Alberts, et al. 1994.Molecular Biology of the Cell, 3rd Edition, pp. 403-404, 453. New York: garland Publishing.
Alberts, et al. 2002.Molecular Biology of th Cell 4th Edition, pp. 302, 363-364, 379, 435. New York: Garland Publishing.
Gökmen-Polar, et al., Feb. 2001, Elevated Protein Kinase C βII is an Early Promotive Event in Colon Carcinogenesis,Cancer Research, vol. 61, pp. 1375-1381.
Grimaldi, et al. 1989. The t(5;14) chromosomal translocation in a case of acute lymphocytic leukemia joins the interleukin-3 gene to the immunoglobulin heavy chain gene.Blood, 73(8):2081-2085.
Gygi, et al. Mar. 1999. Correlation between Protein and mRNA Abundance in Yeast.Molecular and Cellular Biology, 1720-1730.
Haynes, et al., 1998. Proteome analysis: Biological assay or data archive?Electrophoresis, vol. 19, pp. 1862-1871.
Hu, et al. 2003. Analysis of Genomic and Proteomic Data Using Advanced Literature Mining.Journal of Proteome Research, vol. 2, pp. 405-412.
Konopka, et al. Jun. 1986. Variable Expression of the Translocated c-abl Oncogene in Philadelphia-Chromosome-Positive B-Lymphoid Cell Lines from Chronic Myelogenous Leukemia Patients,National Academy of Sciences of the United States of America, vol. 83, No. 11, pp. 4049-4052.
Lewin, B. 1994. Oncogenes: Gene Expression and Cancer, Chap. 39, pp. 1196-1201.Genes V. New York: Oxford University Press.
Lewin, B. 1997. Regulation of Transcription, Chap. 29, pp. 847-848.Genes VI. New York: Oxford University Press.
Meeker, et al. 1990. Activation of the interleukin-3 gene by chromosome translocation in acute lymphocytic leukemia with eosinophilia.Blood, 76(2):285-289.
Meric, et al. 2002. Translocation initiation in cancer: A novel target for therapy.Molecular Cancer Therapeutics, 1:971-979.
Ohara, et al. 2001. Directional cDNA library construction assisted by the in vitro recombination.Nucleic Acids Research, vol. 29, No e22, pp. 1-8.
Singleton, et al. 1992. Clinical and pathologic significance of the c-erbB-2 (HER-2
eu) oncogene.Pathol. Annu, 1(27):165-190.
Zhigang, et al. 2004. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues and its potential role in prostate carcinogenesis and progression of prostate cancer.World Journal of Surgical Oncology, 2:13.
Hanash, S. 2003. Making sense of microarray data to classify cancer.The Pharmacogenomics Journal, 3:308-311.
Hanash, S. Mar. 2005. Integrated global profiling of cancer.Nature Reviews, Applied Proteomics Collection, pp. 9-14.
Hancock, W. S. 2004. Do We Have Enough Biomarkers?Journal of Proteome Research, 3(4):685.
Wang, et al. 1996. mRNA Differential display: Application in the discovery of novel pharmacological targets.Trends Pharmacol. Sci., 17(8):276-279.
Anderson, et al. 1997. A comparison of selected mRNA and protein abundances in human liver.Electrophoresis, 18:533-537.
Chen, et al. 2002. Discordant protein and mRNA expression in lung adenocarcinomas.Molecular&Cellular Proteomics1,4, pp. 304-313.
Fessler, et al. 2002. A genomic and proteomic analysis of activation of the human neutrophil by lipopolysaccharide and its mediation by p38 mitogen-activated protein kinase.The Journal of Biological Chemistry, 277(35):31291-31302.
Fu, et al. 1996. Translational regulation of human p53 gene expression.The EMBO Journal, 15(16):4392-4401.
Hanna, et al. Aug. 1999. HER-2
eu breast cancer predictive testing.Pathology Associates Medical Laboratories.
Hyman, et al. 2002. Impact of DNA amplification on gene expression patterns in breast cancer.Cancer Research, 62:6240-6245.
Jang, et al. 1997. An examination of the effects of hypoxia, acidosis, and glucose starvation on the expression of metastatis-associated genes in murine tumor cells.Clin. Exp. Metastasis, 15(5):469-483. (Abstract).
Labaer, Joshua. 2003. Letter to the editor: Mining the literature and large datasets.Nature Biotechnology, 21(9):976-977.
Lian, et al. 2001. Genomic and proteomic analysis of the myeloid differentiation program.Blood, 98(3):513-524.
Lichtinghagen, et al. 2002. Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissue.European Urology, 42:398-406.
ØRNTOFT, et al. 2002. Genome-wide study of gene copy numbers, transcripts, and protein levels in pairs of non-invasive and invasive human transitional cell carcinomas,Molecular&Cellular Proteomics, 1:37-45.
Pollack, et al. 2002. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors.PNAS, 99(20):12963-12968.
Powell, et al. 1998, Expression of cytochrome P4502E1 in human liver: Assessment by mRNA, genotype and phenotype.Pharmacogenetics, 8:411-421. (Abstract).
Tokunaga, et al. 2000. Applic
Goddard Audrey
Godowski Paul J
Grimaldi J Christopher
Gurney Austin L
Wood William I
Barnes Elizabeth M.
Blanchard David J.
Genentech Inc.
Huff Sheela J.
Knobbe Martens Olson & Bear LLP
LandOfFree
Pro180 polypeptide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pro180 polypeptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pro180 polypeptide will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3762486